Clinical Trial Details


Research Study Summary

C. diff


Let’s Try to Break the Cycle

If a patient has C. diff now, they have up to a 60% chance of having C. diff again.*

The MODIFY Study in testing the safety, effectiveness and tolerability of an investigational drug to see if it can help prevent C. diff reoccurrences.

Participants will receive study-related exams and study drug at no charge. There are risks associated with participation in this clinical research study. They study doctor will explain the study requirements, possible benefits, and potential risks to you before you decide to participate.

Patient Inclusion Criteria:
Eligible participants must:

  • Be at least 18 years of age
  • Have a diagnosis of C. diff (including a positive stool test)

To Learn more

CW ID: 180813
Date Last Changed: July 19, 2013

Clinical Trial Snapshot

Both Male and Female
18 and up
Overall Status
Facility Type


Lorraine Breuer, Vice President for Research
Parker Jewish Institute
271-11 76th Avenue
New Hyde Park, NY 11040
Phone: 718-289-2102
Fax: 718-289-2248

View Map

Research Center Information:

Parker Jewish Institute

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.